Aurobindo Pharma consolidated net profit rises 45.18% in the March 2020 quarter

Sales rise 16.56% to Rs 6063.40 crore

Net profit of Aurobindo Pharma rose 45.18% to Rs 849.83 crore in the quarter ended March 2020 as against Rs 585.38 crore during the previous quarter ended March 2019. Sales rose 16.56% to Rs 6063.40 crore in the quarter ended March 2020 as against Rs 5201.98 crore during the previous quarter ended March 2019.

For the full year,net profit rose 19.72% to Rs 2830.97 crore in the year ended March 2020 as against Rs 2364.73 crore during the previous year ended March 2019. Sales rose 18.27% to Rs 22737.95 crore in the year ended March 2020 as against Rs 19225.92 crore during the previous year ended March 2019.

 

ParticularsQuarter EndedYear EndedMar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.Sales6063.405201.98 17 22737.9519225.92 18 OPM %21.3920.32 -21.1520.24 - PBDT1297.671039.14 25 4735.863847.36 23 PBT1065.26852.52 25 3769.153179.41 19 NP849.83585.38 45 2830.972364.73 20

Powered by Capital Market - Live News